A Silver Lining in the VAD Sky

Completed · Not applicable

Conditions studied: LVAD (Left Ventricular Assist Device) Driveline Infection

In brief

The investigators propose to conduct a prospective randomized trail (RCT) of a driveline management protocol. The study will be initiated at UCSF from January 1st 2022 to December 31st 2022 as a pilot to be extended to other sites with the ultimate goal to develop a multi-center RCT. The driveline dressing protocol studied will include a silver-based dressing barrier as well as a dressing change protocol and material designed to reduce the risk of driveline dressing induced dermatitis and allergies. Assessment will include DLI rates, DLI speciation, dermatitis rate, comfort, ease of use, compliance and cost

Key facts

Study ID

NCT05163392

Run by

University of California, San Francisco

People needed

25

Starts

2022-02-01

Expected to finish

2026-01-26

Last updated by the study team

2026-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• >18 years of age
• Implanted with LVAD as DT or BTT at the Academic Medical Center with implantation scheduled between January 1st, 2022 and December 31st, 2022

You may not qualify if…

• A history of DLI
• A history of sternal wound infection
• Implantation secondary to VAD exchange for device infection

Where it is running

• UCSF Parnassus — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.